This episode is a deep dive into the science and practicalities of cryopreservation, featuring Emil Kendziorra, CEO of Tomorrow Bio. Emil explains the intricate process, its history, current advancements, and future possibilities, addressing both the technical and ethical dimensions. The episode covers everything from emergency stabilization to long-term storage and future revival.

Key Points:

Emil Kendziorra’s Tomorrow Bio offers cryopreservation as a way to bridge to future medical breakthroughs, preserving bodies using advanced methods to avoid cellular damage. While uncertainties remain, Kendziorra believes that cryonics is a scientifically plausible option to extend life, making it increasingly accessible and accepted.

• Cryopreservation’s Evolving Accessibility: Emil Kendziorra aims to make cryopreservation a simple choice rather than a lifestyle, enabling anyone to opt in without deep ideological commitment.
• Concept and Terminology: Cryopreservation, also known as cryonics or biostasis, involves ultra-low temperature storage to preserve bodies until future advancements can potentially reverse death.
• Modern Approach vs. Freezing: Unlike older methods that caused cellular damage by forming ice crystals, modern techniques replace water in the body with cryoprotective agents, creating a glass-like state that avoids freezing.
• Current Scientific Feasibility: Though the reanimation of large organisms isn’t yet possible, studies show successful cryopreservation and revival in small organisms and organs, hinting at future possibilities.
• Cultural Shifts and Funding: Cryonics has moved from a fringe concept to a scientifically credible field, with increasing support from the scientific community and public interest in its potential to extend life.
• Practical Logistics and Cost: Sign-ups involve a legal donation to science, funded mainly through life insurance policies, with long-term storage options in well-insulated, liquid nitrogen-filled "dewars" in Switzerland.
• Resuscitation Ethics and Timing: Revival criteria include reversibility of the preservation process, a cure for the initial cause of death, and a realistic lifespan post-revival.
• Uncertainties and Hope: While unknowns remain, the field operates on educated guesses rather than proof, grounded in medical history where many now-routine procedures were once thought impossible.